Correlation Between Morgan Stanley and Abbott Laboratories

Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Abbott Laboratories at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Abbott Laboratories into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Morgan Stanley Direct and Abbott Laboratories, you can compare the effects of market volatilities on Morgan Stanley and Abbott Laboratories and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Abbott Laboratories. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Abbott Laboratories.

Diversification Opportunities for Morgan Stanley and Abbott Laboratories

0.65

Correlation Coefficient

Morgan Stanley  Abbott Laboratories

Poor diversification

The 3 months correlation between Morgan and Abbott is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and Abbott Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abbott Laboratories and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with Abbott Laboratories. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abbott Laboratories has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Abbott Laboratories go up and down completely randomly.

Pair Corralation between Morgan Stanley and Abbott Laboratories

Given the investment horizon of 90 days Morgan Stanley Direct is expected to generate 1.39 times more return on investment than Abbott Laboratories. However, Morgan Stanley is 1.39 times more volatile than Abbott Laboratories. It trades about 0.04 of its potential returns per unit of risk. Abbott Laboratories is currently generating about 0.02 per unit of risk. If you would invest  1,862  in Morgan Stanley Direct on October 10, 2024 and sell it today you would earn a total of  209.00  from holding Morgan Stanley Direct or generate 11.22% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	48.4%
Values	Daily Returns

Morgan Stanley Direct  vs.  Abbott Laboratories

Morgan Stanley Direct

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley Direct are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent fundamental indicators, Morgan Stanley is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Abbott Laboratories

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Abbott Laboratories are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable essential indicators, Abbott Laboratories is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Morgan Stanley and Abbott Laboratories

The main advantage of trading using opposite Morgan Stanley and Abbott Laboratories positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Abbott Laboratories can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will offset losses from the drop in Abbott Laboratories' long position.

The idea behind Morgan Stanley Direct and Abbott Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.